Integer Holdings Corporation (ITGR) has a MoatMap StockRank of 79/100 based on Quality (54/100), Value (45/100), and Momentum (61/100) factor scores. The current signal is BUY. As the world's largest medical device contract manufacturer (CDMO), Integer is a prime beneficiary of the outsourcing trend among medical tech OEMs seeking to de-risk supply chains and regionalize production. Integer possesses a formidable regulatory moat and high switching costs, as its components are designed directly into FDA-approved life-saving devices (cardiac, neuromodulation). This creates an incredibly sticky, high-ROIC business model with pricing power that mirrors the biologics CDMO cycle.
Integer Holdings is a leading medical device outsource (MDO) manufacturer specializing in high-quality components and finished devices for cardiac, neuromodulation, vascular, and orthopedic markets. It benefits from deep expertise in highly specialized medical device manufacturing, stringent quality systems, and long-standing relationships with top-tier OEMs. The company is a critical supply chain partner, enabling innovation and production of life-saving and enhancing medical technologies.
| Price | $92.74 |
| Market Cap | $3.1B |
| P/E (TTM) | 23.01 |
| P/E (Forward) | 13.62 |
| Price/Book | 1.86 |
| Return on Equity | 8.6% |
| Return on Invested Capital | 5.1% |
| Debt/Equity | 81.41 |
| Gross Margin | 26.8% |
| Operating Margin | 8.2% |
| Revenue Growth | 0.5% |
| Free Cash Flow | $98M |
Integer Holdings Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).